The foundation was not solid.
In the long arc of public health, the integrity of evidence is the foundation upon which trust is built or lost. Three scientific studies, cited by Robert F. Kennedy Jr. to justify sweeping changes to America's vaccine schedule, are now unraveling under scrutiny — some facing retraction, others under federal investigation for methodological failures and data misrepresentation. The episode raises a question as old as governance itself: what happens to decisions made in the name of the people when the reasoning behind them proves unsound?
- The studies RFK Jr. used to justify major vaccine policy shifts are collapsing under scrutiny, with at least one already entering the retraction process.
- Federal investigators and independent scientists have identified serious flaws — questionable methodology, data integrity problems, and apparent misrepresentation of findings — threatening the entire evidentiary foundation of recent policy changes.
- The FDA's decision to block publication of certain vaccine safety research has triggered a Senate investigation, forcing a reckoning over whether legitimate science was suppressed or flawed work was shielded from exposure.
- Public health officials now face the daunting task of walking back arguments that millions of Americans have already absorbed, in a climate where institutional trust is already fragile.
- The trajectory is clear: if the foundational studies do not survive serious examination, the policy decisions built upon them may need to be reconsidered — with real consequences for vaccination rates and disease prevention.
Robert F. Kennedy Jr. built his case for overhauling America's vaccine schedule on three scientific studies. Those studies are now crumbling, and their collapse is forcing hard questions about how consequential public health decisions came to rest on research that regulators and independent scientists say does not hold up.
The studies were cited repeatedly by Kennedy and his allies as evidence that the existing vaccine schedule posed hidden risks — claims that helped justify policy changes affecting millions of Americans. Investigators have since found serious problems: methodological flaws, data integrity issues, and apparent misrepresentation of findings. At least one study has entered the retraction process. The FDA's decision to block publication of certain vaccine safety research added further complexity, prompting Senate lawmakers to investigate whether legitimate safety data was suppressed or whether flawed work was being passed off as credible science.
The tension at the heart of this story is not new. Public health officials have long maintained that the vaccine program is both safe and necessary — that the diseases it prevents pose far greater risk to children than the vaccines themselves. Kennedy's growing influence pushed that debate into policy meetings, legislative hearings, and the broader public conversation. Now the basic work of science — checking the facts — is doing what institutions failed to do earlier: examining whether the foundation was solid. It was not.
The human stakes are real. Every child born in America is touched by vaccine policy. If major shifts were made on the basis of studies that cannot withstand scrutiny, those decisions may need to be revisited. Public health officials face the difficult task of explaining to a public that has already absorbed Kennedy's arguments that the research behind them was flawed. Rebuilding that trust — and determining what the Senate investigation ultimately reveals about the FDA's role — will define what comes next for American vaccine policy.
Robert F. Kennedy Jr. built a case for sweeping changes to America's vaccine policy on the foundation of three scientific studies. Those studies are now crumbling under scrutiny, and the collapse is raising hard questions about how a major shift in public health direction came to rest on research that regulators and independent scientists say does not hold up.
The three studies were cited repeatedly by Kennedy and his allies as evidence that the existing vaccine schedule posed hidden risks—claims that helped justify policy changes affecting millions of Americans. But investigators have found serious problems with the research. Some studies face retraction. Others are being examined by federal agencies for methodological flaws, data integrity issues, or misrepresentation of findings. The FDA has also blocked publication of certain vaccine safety research, a move that prompted Senate lawmakers to open an investigation into whether legitimate safety data was being suppressed or whether flawed work was being presented as credible science.
The timing matters. Kennedy's influence over vaccine policy has grown substantially in recent years, and the studies he cited became touchstones for his argument that the current immunization schedule needed fundamental revision. Public health officials, by contrast, have long maintained that the existing vaccine program is both safe and necessary—that the diseases it prevents pose far greater risk to children than the vaccines themselves. The tension between these positions has played out in policy meetings, legislative hearings, and the court of public opinion.
Now that tension is being resolved by the basic work of science: checking the facts. When researchers and regulators examined the three studies closely, they found the foundation was not solid. The problems ranged from questionable methodology to apparent misinterpretation of data. In at least one case, the retraction process has begun. In others, the scrutiny is ongoing but the trajectory is clear—these are not studies that will survive serious examination intact.
The Senate investigation into FDA actions adds another layer to the story. If the agency blocked publication of legitimate safety research, that would be a serious breach of scientific integrity. But if the FDA was protecting the scientific record from flawed or misleading work, that is a different matter entirely. The investigation will need to sort through what was blocked, why, and whether the decision was justified. What seems clear already is that the line between legitimate safety inquiry and anti-vaccine advocacy had become blurred in ways that allowed weak research to gain outsized influence.
The human stakes are substantial. Vaccine policy affects every child born in America. If major policy shifts were made on the basis of studies that do not actually support those shifts, then the decisions themselves may need to be reconsidered. Public health officials are now facing the task of explaining to a public that has already absorbed Kennedy's arguments that the research underlying those arguments was flawed. That is a difficult conversation to have, and it will likely take time to rebuild confidence in the institutions that oversee vaccine safety.
What happens next will depend partly on how thoroughly the investigations proceed and how clearly the findings are communicated. It will also depend on whether the policy changes that were made get reversed, modified, or allowed to stand despite the evidentiary problems. The credibility of American vaccine policy—and the public trust that sustains it—may hinge on how honestly and completely these questions are answered.
Notable Quotes
The existing vaccine program is both safe and necessary—that the diseases it prevents pose far greater risk to children than the vaccines themselves— Public health officials
The Hearth Conversation Another angle on the story
Why did these three studies carry so much weight in the first place? What made them seem credible to policymakers?
They offered something that fit a narrative people wanted to believe—that the vaccine schedule was riskier than we thought. When you're looking for evidence to support a position you already hold, studies that seem to provide it get cited and amplified. The problem is that citation and influence don't equal scientific validity.
But the FDA blocking publication of vaccine safety research—doesn't that suggest the agency was hiding something?
That's the question the Senate is asking. But blocking publication could mean different things. It could mean suppressing inconvenient truth, or it could mean preventing flawed work from entering the scientific record under the guise of legitimate research. We need to know which one actually happened.
How does a researcher or policymaker tell the difference between a real safety concern and advocacy dressed up as science?
Honestly, it's harder than it should be. You have to look at the methodology, check whether the data actually supports the conclusions, see if other researchers can replicate the findings. That work takes time and expertise. It's easier to just accept what fits your worldview.
What's the damage if people lose faith in vaccine policy because of this?
Vaccination rates could drop. Diseases that we've nearly eliminated could come back. The damage isn't abstract—it's measured in hospitalizations and deaths, mostly among children too young to have been vaccinated yet. That's why getting this right matters so much.